Alcohol Use and Relationships - III
This study is currently recruiting participants.
Verified December 2012 by The University of Tennessee Knoxville
Sponsor:
The University of Tennessee Knoxville
Information provided by (Responsible Party):
The University of Tennessee Knoxville
ClinicalTrials.gov Identifier:
NCT01753986
First received: December 17, 2012
Last updated: December 19, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators hypothesize that individuals receiving the brief substance use intervention will have better substance use and intimate partner violence outcomes than individuals receiving the general health improvement intervention. All participants receive standard batterer intervention.
| Condition | Intervention | Phase |
|---|---|---|
|
Intimate Partner Violence Substance Use |
Behavioral: Brief Alcohol Intervention plus Standard Batterer Intervention Behavioral: General Health Improvement Intervention plus Standard Batterer Intervention |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Impact of Brief Substance Use Intervention on Substance Use and Intimate Partner Violence |
Further study details as provided by The University of Tennessee Knoxville:
Primary Outcome Measures:
- lower levels of intimate partner violence [ Time Frame: one year ] [ Designated as safety issue: No ]lower levels of any violence and severe intimate partner violence (psychological, physical, sexual, injuries)
Secondary Outcome Measures:
- lower levels of substance use (alcohol and drug) [ Time Frame: one year ] [ Designated as safety issue: No ]
Other Outcome Measures:
- fewer arrests for violence recidivism [ Time Frame: one year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 500 |
| Study Start Date: | December 2012 |
| Estimated Study Completion Date: | December 2019 |
| Estimated Primary Completion Date: | December 2018 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Brief Alcohol Intervention plus Standard Batterer intervention
Brief Alcohol Intervention plus 40 hours of Standard Batterer intervention
|
Behavioral: Brief Alcohol Intervention plus Standard Batterer Intervention
Brief Alcohol Intervention plus 40 hours or Standard Batterer Intervention
|
|
Placebo Comparator: General Health Improvement plus Standard batterer intervention
General Health Improvement Intervention plus 40 hours of Standard Batterer intervention
|
Behavioral: General Health Improvement Intervention plus Standard Batterer Intervention
General Health Improvement Intervention plus 40 hours of Standard Batterer Intervention
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Participation in Batterer Intervention Program in RI
- Hazardous Drinking
Exclusion Criteria:
- drinks too much
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01753986
Locations
| United States, Rhode Island | |
| Butler Hospital | Recruiting |
| Providence, Rhode Island, United States, 02906 | |
| Contact: Gregory Stuart, PhD gstuart@utk.edu | |
| Sub-Investigator: Yael Schonbrun, PhD | |
Sponsors and Collaborators
The University of Tennessee Knoxville
More Information
No publications provided
| Responsible Party: | The University of Tennessee Knoxville |
| ClinicalTrials.gov Identifier: | NCT01753986 History of Changes |
| Other Study ID Numbers: | 1210-005 |
| Study First Received: | December 17, 2012 |
| Last Updated: | December 19, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Ethanol Anti-Infective Agents, Local Anti-Infective Agents Therapeutic Uses |
Pharmacologic Actions Central Nervous System Depressants Physiological Effects of Drugs Central Nervous System Agents |
ClinicalTrials.gov processed this record on May 16, 2013